213 related articles for article (PubMed ID: 25762530)
1. Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.
Lubet RA; Scheiman JM; Bode A; White J; Minasian L; Juliana MM; Boring DL; Steele VE; Grubbs CJ
Cancer Prev Res (Phila); 2015 Apr; 8(4):296-302. PubMed ID: 25762530
[TBL] [Abstract][Full Text] [Related]
2. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
3. 4-Hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers in mice: characterization of FHIT and survivin expression and chemopreventive effects of indomethacin.
Lubet RA; Huebner K; Fong LY; Altieri DC; Steele VE; Kopelovich L; Kavanaugh C; Juliana MM; Soong SJ; Grubbs CJ
Carcinogenesis; 2005 Mar; 26(3):571-8. PubMed ID: 15591090
[TBL] [Abstract][Full Text] [Related]
4. Chemopreventive efficacy of naproxen and nitric oxide-naproxen in rodent models of colon, urinary bladder, and mammary cancers.
Steele VE; Rao CV; Zhang Y; Patlolla J; Boring D; Kopelovich L; Juliana MM; Grubbs CJ; Lubet RA
Cancer Prev Res (Phila); 2009 Nov; 2(11):951-6. PubMed ID: 19892664
[TBL] [Abstract][Full Text] [Related]
5. Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers.
Mohammed A; Miller MS; Lubet RA; Suen CS; Sei S; Shoemaker RH; Juliana MM; Moeinpour FL; Grubbs CJ
Cancer Prev Res (Phila); 2020 Mar; 13(3):273-282. PubMed ID: 31818850
[TBL] [Abstract][Full Text] [Related]
6. Preventive effects of NSAIDs, NO-NSAIDs, and NSAIDs plus difluoromethylornithine in a chemically induced urinary bladder cancer model.
Nicastro HL; Grubbs CJ; Margaret Juliana M; Bode AM; Kim MS; Lu Y; You M; Milne GL; Boring D; Steele VE; Lubet RA
Cancer Prev Res (Phila); 2014 Feb; 7(2):246-54. PubMed ID: 24346344
[TBL] [Abstract][Full Text] [Related]
7. Screening agents for preventive efficacy in a bladder cancer model: study design, end points, and gefitinib and naproxen efficacy.
Lubet RA; Steele VE; Juliana MM; Grubbs CJ
J Urol; 2010 Apr; 183(4):1598-603. PubMed ID: 20172542
[TBL] [Abstract][Full Text] [Related]
8. Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancers.
Lubet RA; Fischer SM; Steele VE; Juliana MM; Desmond R; Grubbs CJ
Int J Cancer; 2008 Nov; 123(10):2254-9. PubMed ID: 18712722
[TBL] [Abstract][Full Text] [Related]
9. Chemopreventive efficacy of piroxicam administered alone or in combination with lycopene and beta-carotene on the development of rat urinary bladder carcinoma after N-butyl-N-(4-hydroxybutyl)nitrosamine treatment.
Okajima E; Ozono S; Endo T; Majima T; Tsutsumi M; Fukuda T; Akai H; Denda A; Hirao Y; Okajima E; Nishino H; Nir Z; Konishi Y
Jpn J Cancer Res; 1997 Jun; 88(6):543-52. PubMed ID: 9263531
[TBL] [Abstract][Full Text] [Related]
10. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and anti-inflammatory properties of diindolylmethane and lupeol against N-butyl-N-(4-hydroxybutyl) nitrosamine induced bladder carcinogenesis in experimental rats.
Prabhu B; Balakrishnan D; Sundaresan S
Hum Exp Toxicol; 2016 Jun; 35(6):685-92. PubMed ID: 26251508
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Okazaki K; Yamagishi M; Son HY; Imazawa T; Furukawa F; Nakamura H; Nishikawa A; Masegi T; Hirose M
Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
[TBL] [Abstract][Full Text] [Related]
14. Promotion effects of acetoaceto-o-toluidide on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced bladder carcinogenesis in rats.
Yukimatsu N; Gi M; Okuno T; Fujioka M; Suzuki S; Kakehashi A; Yanagiba Y; Suda M; Koda S; Nakatani T; Wanibuchi H
Arch Toxicol; 2019 Dec; 93(12):3617-3631. PubMed ID: 31673724
[TBL] [Abstract][Full Text] [Related]
15. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder.
Rao KV; Detrisac CJ; Steele VE; Hawk ET; Kelloff GJ; McCormick DL
Carcinogenesis; 1996 Jul; 17(7):1435-8. PubMed ID: 8706245
[TBL] [Abstract][Full Text] [Related]
16. Low susceptibility of Long-Evans Cinnamon rats to N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder carcinogenesis and inhibitory effect of urinary copper.
Chone Y; Kinouchi T; Yamada T; Suzuki Y; Kitaura K; Jiao Z; Minami T; Bando Y; Uehara H; Mochizuki M; Ohnishi Y; Izumi K
Jpn J Cancer Res; 2000 Jan; 91(1):16-24. PubMed ID: 10744040
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive efficacy of Targretin in rodent models of urinary bladder, colon/intestine, head and neck and mammary cancers.
Lubet RA; Clapper ML; McCormick DL; Pereira MA; Chang WC; Steele VE; Fischer SM; Juliana MM; Grubbs CJ
Oncol Rep; 2012 May; 27(5):1400-6. PubMed ID: 22307264
[TBL] [Abstract][Full Text] [Related]
18. Dose dependency of γ-H2AX formation in the rat urinary bladder treated with genotoxic and nongenotoxic bladder carcinogens.
Yamada T; Toyoda T; Matsushita K; Morikawa T; Ogawa K
J Appl Toxicol; 2020 Sep; 40(9):1219-1227. PubMed ID: 32203627
[TBL] [Abstract][Full Text] [Related]
19. Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers.
Prasain JK; Jones K; Moore R; Barnes S; Leahy M; Roderick R; Juliana MM; Grubbs CJ
Oncol Rep; 2008 Jun; 19(6):1565-70. PubMed ID: 18497966
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
Okazaki K; Umemura T; Imazawa T; Nishikawa A; Masegi T; Hirose M
Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
